Skip to main

Clovis Oncology

CLVS is nowCLVSQ
CLVS
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More

Frequently Asked Questions (FAQ)

As of Jul 25, 2025, the market cap for CLVS stock is $2.18M

The current P/E ratio for CLVS stock is -0.01

The 52-week high for CLVS stock is $2.87. The current CLVS stock price $undefined is 100.00% below its 52-week high

The 52-week low for CLVS stock is $0.01. The current CLVS stock price $undefined has increased 100.00% from its 52-week low

No, the CLVS stock does not pay dividends to its shareholders

How to buy CLVS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CLVS stock

    Navigate to the Explore page. Then, type CLVS into the search bar. When you see CLVS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CLVS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Clovis Oncology Stock Earnings

The value each CLVS share was expected to gain vs. the value that each CLVS share actually gained.

Clovis Oncology (CLVS) reported Q3 2022 earnings per share (EPS) of -$0.39, missing estimates of -$0.37 by 5.41%. In the same quarter last year, Clovis Oncology's earnings per share (EPS) was -$0.56. Clovis Oncology is expected to release next earnings on 11/09/2022, with an earnings per share (EPS) estimate of $0.

Buy Clovis Oncology (CLVS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.